Elevance Health vs UnitedHealth
ELV and UNH side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ELV and UNH compare
UnitedHealth is the larger company, worth 4.0 times as much as Elevance Health ($365B against $91.1B).
On earnings, Elevance Health is cheaper: it trades at 18.7× trailing earnings, against 26.2× for UnitedHealth.
UnitedHealth grew revenue faster over the last twelve months (6.5% versus 6.3% for Elevance Health).
UnitedHealth keeps more of each dollar of sales as profit, with a net margin of 3.1% compared with 2.5% at Elevance Health.
Both pay dividends: Elevance Health yields 1.6% and UnitedHealth 2.2%.
Elevance Health scores higher on the StockData Score (15 against 11 for UnitedHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ELV | UNH |
|---|---|---|
| Size and price | ||
| Market cap | $91.1B | $365B |
| Share price | $420.07 | $406.97 |
| Change, 1 year | 24.9% | 14.6% |
| Change, 5 years | −0.47% | −10.7% |
| Beta (5Y) | 0.44 | 0.32 |
| Employees | 97K | 390K |
| StockData Score | ||
| Total score | 15 (better) | 11 |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 2 | 2 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 18.7× (better) | 26.2× |
| P/S | 0.5× (better) | 0.8× |
| P/B | 2.0× | – |
| EV/EBITDA | 12.4× (better) | 15.9× |
| P/FCF | 14.5× (better) | 15.5× |
| PEG | 14.81 | – |
| FCF yield | 6.9% (better) | 6.5% |
| Fair value | $477.08 | – |
| Margin of safety | 11.9% | – |
| Growth | ||
| Revenue growth (TTM) | 6.3% | 6.5% (better) |
| Revenue growth, 5Y average | 10.3% | 11.7% (better) |
| Net income growth (TTM) | −7.4% (better) | −33.7% |
| EPS growth (TTM) | −4.3% (better) | −32.7% |
| EPS growth, 5Y average | 7.0% (better) | −3.8% |
| Profitability | ||
| Gross margin | 89.1% (better) | 88.6% |
| Operating margin | 2.7% | 4.8% (better) |
| Net margin | 2.5% | 3.1% (better) |
| FCF margin | 3.1% | 5.2% (better) |
| Return on equity | 11.2% | – |
| Return on invested capital | 11.5% | – |
| Financial health | ||
| Debt / equity | 0.69 | – |
| Net debt / EBITDA | −0.70 | 1.61 (better) |
| Interest coverage | 3.8× | 5.6× (better) |
| Current ratio | 1.52 (better) | 0.78 |
| Altman Z-score | 3.03 | 3.12 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.6% | 2.2% (better) |
| Payout ratio | 30.3% | 57.3% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 12.6% |
| Buyback yield | 3.0% (better) | 0.28% |
| Shareholder yield | 4.6% (better) | 2.5% |
| Ownership | ||
| Held by institutions | 94.0% | 87.7% |
| Held by insiders | 0.19% | 0.18% |
| Insider net buying, 12 months | $493K (better) | −$945K |
| Superinvestors holding | 8 | 8 |
| Short interest, % of float | 2.2% | 1.8% |
Go deeper
- ELV stock overview
- ELV income statement
- ELV valuation and score
- UNH stock overview
- UNH income statement
- UNH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.